S100B

S100B Overview

English NameProtein NefApproved Drugs0
Drugs in Clinical Trials1Target Synonymnef,Negative factor,3'ORF,Protein Nef,F-protein
Highest Development StagePhase 1 Clinical
English NameProtein Nef
Target Synonymnef,Negative factor,3'ORF,Protein Nef,F-protein
Approved Drugs0
Drugs in Clinical Trials1
Highest Development StagePhase 1 Clinical

S100B Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    His Tag (1)

  • Conjugate

    Unconjugated (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
S1B-H5143
Human
E. coli
Human S100B Protein, His Tag
Total: 1
  • 1

S100B Background

S-100 protein beta chain (S100B),a member of the S-100 family, is also known as S-100 protein subunit beta and S100 calcium-binding protein B, which contains two EF-hand domains. S100B can weakly bind calcium but bind zinc very tightly-distinct binding sites with different affinities exist for both ions on each monomer. Also, S100B can bind to and initiate the activation of STK38 by releasing autoinhibitory intramolecular interactions within the kinase. Interaction with AGER after myocardial infarction,S100B may play a role in myocyte apoptosis by activating ERK1/2 and p53/TP53 signaling. Fuethermore,S100B could assist ATAD3A cytoplasmic processing, preventing aggregation and favoring mitochondrial localization. S100B may mediate calcium-dependent regulation on many physiological processes by interacting with other proteins, such as TPR-containing proteins, and modulating their activity.

S100B Synonyms

S100B,NEF,S100,S100beta

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
HIV clade B mRNA dendritic cell therapy (Immunomic Therapeutics/Universite Libre de Bruxelles)Phase 1 ClinicalImmunomic Therapeutics IncHIV Infections
Details
  • Overview
  • Product List
  • Clinical Drug Information